IP Library Assignment 019795/0626
Patent Assignment
Reel/Frame 019795/0626

Change of Name and Address

Recorded: 2007-09-06 Received: 2007-09-06 Pages: 20
Assignor
Assignee
GALDERMA RESEARCH & DEVELOPMENT
2400 ROUTE DES COLLES LES TEMPLIERS, 06410 BIOT, FRX, FRANCE
Covered Properties (40)
Novel Phenylboronic Acid Compounds and Intermediates and Processes for the Preparation Thereof
Application: 11/454,859 →
Novel Modulators of the Ppar-Type Receptors and Pharmaceutical/Cosmetic Applications Thereof
Application: 11/450,392 →
Treating inflammation with ondansetron and pharmaceutical compositions comprised thereof
Application: 11/450,390 →
Novel Ligand Activators of the Rar Receptors and Pharmaceutical/Cosmetic Applications Thereof
Application: 11/448,782 →
Novel Ligand Activators of the Rar Receptors and Pharmaceutical/Cosmetic Applications Thereof
Application: 11/448,830 →
Cosmetic/dermatological applications of PPAR receptor activators
Application: 11/444,371 →
Pharmaceutical spray compositions comprising a bioactive agent, at least one volatile silicone and a non-volatile oily phase
Application: 11/432,410 →
Pharmaceutical/Cosmetic Compositions Comprising Novel Ligands That Activate Rar Receptors
Application: 11/403,916 →
O/W emulsions comprising micronized biologically active agents
Application: 11/378,483 →
Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase
Application: 11/315,259 →
Novel Compounds That Modulate Ppary Type Receptors and Cosmetic/Pharmaceutical Compositions Comprised Thereof
Application: 11/311,449 →
Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
Application: 11/227,185 →
Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof
Application: 11/212,714 →
Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
Application: 11/202,059 →
Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
Application: 11/202,019 →
Invert emulsions comprising at least one active agent sensitive to water and cosmetic/dermatological applications thereof
Application: 11/196,301 →
Chemical stabilization of solubilized retinoids and aqueous compositions comprised thereof
Application: 11/154,655 →
Aqueous-alcoholic depigmenting gels
Application: 11/150,176 →
Novel Polycyclic Compounds Which Modulate Ppargamma Type Receptors and Cosmetic/Pharmaceutical Compositions Comprised Thereof
Application: 11/149,551 →
Novel Biaromatic Compounds Which Activate Ppargamma Type Receptors and Cosmetic/Pharmaceutical Compositions Comprised Thereof
Application: 11/135,499 →
Novel Biaromatic Compounds Which Activate Ppary Type Receptors and Cosmetic/Pharmaceutical Compositions Comprised Thereof
Application: 11/131,302 →
Novel Ligand Antagonists of Rar Receptors and Pharmaceutical/Cosmetic Applications Thereof
Application: 11/116,344 →
Novel Vitamin D Analogues
Application: 11/066,795 →
Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent
Application: 11/042,519 →
Novel Ligand Inhibitors of the Rar Receptors, Process for Preparing Same and Therapeutic/Cosmetic Applications Thereof
Application: 10/991,430 →
Novel Ligand Inhibitors of the Rar Receptors, Process for Preparing Same and Therapeutic/Cosmetic Applications Thereof
Application: 10/991,510 →
Invert emulsions comprising DHEA
Application: 10/767,814 →
Bicyclic Aromatic Compounds and Pharmaceutical/Cosmetic Compositions Comprised Thereof
Application: 10/630,872 →
Biaromatic Compound Activators of Ppary-Type Receptors
Application: 10/360,615 →
Biaromatic Ligand Activators of Ppargamma Receptors
Application: 10/326,054 →
Triaromatic Vitamin D Analogues
Application: 10/315,121 →
Novel Angiogenesis Inhibitors and Pharmaceutical and Cosmetic Use Thereof
Application: 10/290,388 →
Vitamin D Analogues
Application: 10/130,794 →
Vitamin D Analogues
Application: 10/130,941 →
Retinoid Compounds Suited for Antibacterial Applications
Application: 10/207,777 →
Novel Heteroethynylenic Compounds and Pharmaceutical and Cosmetic Compositions Containing Them
Application: 10/192,651 →
Apoptosis Inducing Adamantyl Derivatives and Their Usage as Anti-Cancer Agents, Especially for Cervical Cancers and Dysplasias
Application: 10/176,778 →
Shared Reference Station
Application: 10/079,252 →
Vitamin D Analogues
Application: 09/830,973 →
Diarylselenide Compounds and Their Use in Human or Veterinary Medicine and in Cosmetics
Application: 09/719,219 →